Zhejiang Cancer Hospital
Clinical trials sponsored by Zhejiang Cancer Hospital, explained in plain language.
-
New drug cocktail aims to fight tough brain cancers in frail patients
Disease control Recruiting nowThis study is testing whether a combination of three drugs—thiotepa, pirtobrutinib, and sintilimab—can help control a type of lymphoma that affects the brain or has returned after previous treatment. It is for adults who are frail or whose cancer has not responded to standard the…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New combo therapy aims to shrink tumors before stomach cancer surgery
Disease control Recruiting nowThis study is testing whether adding an experimental drug called IBI363 to standard chemotherapy helps people with a specific type of locally advanced stomach cancer. The goal is to shrink the tumor before surgery and control the disease afterward. The study will enroll 60 adults…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Tracking a new hope for advanced breast cancer patients
Disease control Recruiting nowThis study aims to see how well a drug called sacituzumab govitecan works for patients with advanced HER2-negative breast cancer in real-world medical settings across China. It will follow about 200 patients who have already received this treatment to measure how long the cancer …
Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope for ovarian cancer: testing a potentially gentler, targeted treatment
Disease control Recruiting nowThis study is testing a new combination treatment for advanced ovarian cancer. It pairs a standard chemotherapy drug (carboplatin) with a newer, targeted drug called Distamab Vedotin (RC48), which is designed to attack cancer cells with a specific marker (HER2). The goal is to se…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for tough cases: direct liver attack on stubborn breast cancer
Disease control Recruiting nowThis study is testing a new approach for advanced breast cancer that has spread to the liver and hasn't responded to standard treatments. It delivers two chemotherapy drugs directly into the liver's blood supply to try to control the cancer there. The main goal is to see how long…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New hope for tough breast cancers: trial tests Triple-Threat combo
Disease control Recruiting nowThis study is testing whether adding one or two new drugs to standard hormone therapy can help control advanced breast cancer that has stopped responding to previous treatments. It will enroll 118 women whose cancer is hormone-receptor positive and HER2-negative, and has grown de…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
Breast cancer trial tests treatment swap strategy to outsmart tumor resistance
Disease control Recruiting nowThis study aims to see if switching between two different targeted drug combinations helps control advanced HER2-positive breast cancer for a longer time after the first treatment stops working. It will involve 600 women whose cancer has spread and who have already tried one of t…
Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New hope for tough cancer: trial tests powerful drug combo
Disease control Recruiting nowThis study is testing whether adding two newer drugs (an immunotherapy and a blood vessel blocker) to standard chemotherapy helps people with advanced pancreatic cancer live longer. About 292 adults in China who haven't had prior treatment for their advanced cancer will participa…
Phase: PHASE3 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
Cord blood trial aims to boost platelets in cancer patients
Disease control Recruiting nowThis study is testing if an infusion of umbilical cord blood can safely help cancer patients whose platelet counts have dropped dangerously low due to their cancer treatments. The trial will enroll 25 patients aged 12-65 to receive the cord blood infusion and then track their pla…
Phase: PHASE2 • Sponsor: Zhejiang Cancer Hospital • Aim: Disease control
Last updated Mar 05, 2026 14:00 UTC
-
Doctors use CT scans to see how breathing tubes fit
Knowledge-focused Recruiting nowThis study aims to understand how three different types of breathing tubes fit inside patients who are under anesthesia. Researchers will use CT scans to take detailed pictures of the tubes in place in 9 patients. The goal is to gather information that could help doctors choose t…
Phase: NA • Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Scientists track Ginseng's journey through the body
Knowledge-focused Recruiting nowThis study aims to understand how American ginseng affects the body's chemistry in healthy adults. Twenty participants will take ginseng powder daily for two weeks while researchers analyze their urine and blood samples. The goal is to map the changes in body chemistry, not to tr…
Phase: NA • Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC
-
Scientists watch your swallow to build a better mask
Knowledge-focused Recruiting nowThis study aims to understand how normal throat structures move when a person swallows. Researchers will watch this happen in real-time using standard X-ray exams that patients are already getting. The information will be used to help design safer and more comfortable breathing m…
Sponsor: Zhejiang Cancer Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC